BIT to Display Molecular Instrumentation Solutions at AMP 2017
BIT will display three molecular instrument solutions at the AMP 2017 Annual Meeting (taking place November 16-18 at the Calvin L. Rampton Salt Place Convention Center in Salt Lake City, Utah). At BIT’s Booth #626, attendees will be able to investigate a medium-sized Molecular Genotyping Platform as well as two compact molecular diagnostic testing instruments within the fast-growing Rapid Diagnostic POC Testing Solutions field.
Salt Lake City, Utah – BIT (exhibiting at Booth #626) will present three molecular instrumentation solutions at the Association for Molecular Pathology (AMP) 2017 Annual Meeting, November 16-18. Each instrument will showcase a different technology. The AMP Annual Meeting is recognized as the premier gathering for molecular professionals as they seek to obtain critical, analytical patient care intelligence. Nearly 200 globally diverse exhibitors will represent every aspect of molecular diagnostics. Key executive members of BIT’s Global Business Development team will be at Booth #626 to field questions regarding one medium-sized automated molecular genotyping platform; and two compact Rapid Diagnostic POC Testing Instruments (from BIT partners Lucigen and Qorvo) as well as to discuss potential new projects. Anyone interested in scheduling a private meeting is encouraged to email BIT at contact@bit-group.com .
Detailed descriptions of the showcased instruments include:
Automated Molecular Genotyping Platform
This medium-sized platform (based on a fluorescence-labeled, bead chip technology) is designed for transfusion, pharmacological and transplantation assays
Qorvo Universal Bio-Sensor System/ Cartridge Platform
This compact Rapid Diagnostic POC Testing Solution is designed for processing immunoassays while allowing for broad test & sample flexibility
Lucigen In-vitro Diagnostic LAMP-based Platform
This compact Rapid Diagnostic POC Testing Solution is designed for isothermal amplification and detection of various pathogens or nucleic acid analytes. It utilizes BIT POC SMARTModules.
BIT provides contract product development, manufacturing and after-sales services, as well as hematology instruments, for life science, medical and IVD instrumentation OEMs. Quality and regulatory standards include GMP, FDA registered, ISO13485, QSR and CE IVD Directive. BIT‘s global operations in USA, Germany, France & China deliver precision engineered, cost effective systems solutions. Pre-engineered platform technologies reduce development cost and time-to-market; lean manufacturing centers and global supply chain enable competitive product cost.
Contact:
Executive VP, Jari Palander
Phone: +1 (949) 238 1277
J.Palander@BIT-Group.com
www.BIT-Group.com